The comparative efficacy and safety of cholinesterase inhibitors in patients with mild‐to‐moderate Alzheimer's disease: a Bayesian network meta‐analysis

BACKGROUND: Comparative evidence for efficacy and safety of second‐generation cholinesterase inhibitors (ChEIs) is still sparse. OBJECTIVES: The purpose of this research is to compare three ChEIs, donepezil, galantamine and rivastigmine, in patients with mild‐to‐moderate Alzheimer's disease (AD...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Hisanori, Ohnishi, Takashi, Nakagawa, Ryoko, Yoshizawa, Kazutake
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6084309/
https://www.ncbi.nlm.nih.gov/pubmed/26680338
http://dx.doi.org/10.1002/gps.4405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6084309/
https://www.ncbi.nlm.nih.gov/pubmed/26680338
http://dx.doi.org/10.1002/gps.4405

Ejemplares similares